Clinical Scorecard: Evaluating the Diagnostic Efficacy of Frame-Based Stereotactic Biopsies in Precision Neuro-Oncology: A Cross-Sectional Analysis

At a Glance

Key Highlights

• Frame-based stereotactic biopsies yield sufficient tissue for integrated neuropathological diagnosis including molecular genetic analyses.
• Molecular diagnostics such as next-generation sequencing and methylation profiling are essential for modern CNS tumor classification and personalized therapy.
• Surgical trajectory planning and specimen sampling strategy influence the adequacy of tissue for molecular profiling.

Guideline-Based Recommendations

Diagnosis

• Use frame-based stereotactic biopsy for diagnostic workup of unclear, deep-seated intracranial lesions not amenable to safe resection.
• Incorporate molecular analyses (NGS, methylation arrays) alongside histopathology for integrated CNS tumor diagnosis per WHO 2021 classification.

Management

• Perform biopsies under general anesthesia with intraoperative imaging to optimize trajectory planning.
• Sample tissue serially from lesion border to target point to maximize diagnostic yield.

Monitoring & Follow-up

• Postoperative MRI should be used to assess biopsy trajectory accuracy and correlate with tissue adequacy for molecular studies.

Risks

• Low morbidity associated with stereotactic biopsies, but limited tissue quantity may rarely lead to inconclusive diagnosis.

Patient & Prescribing Data

145 consecutive patients with unclear intracranial lesions undergoing frame-based stereotactic biopsy

Majority diagnosed with glioma (63%) or lymphoma (16%); molecular diagnostics enabled integrated diagnosis and potential personalized therapy.

Clinical Best Practices

• Ensure precise stereotactic frame placement and intraoperative imaging fusion for optimal biopsy trajectory.
• Obtain multiple serial specimens along the planned trajectory to increase tissue yield for histological and molecular analyses.
• Integrate molecular genetic testing routinely to meet updated WHO CNS tumor classification standards.
• Evaluate postoperative imaging to refine surgical approach and improve future biopsy adequacy.

References

• WHO Classification of CNS Tumors 2021
• Next-Generation Sequencing in CNS Tumors
• Stereotactic Biopsy Techniques and Outcomes